Target volume definition for three-dimensional conformal radiation therapy of lung cancer
- PMID: 9849380
- DOI: 10.1259/bjr.71.846.9849380
Target volume definition for three-dimensional conformal radiation therapy of lung cancer
Abstract
Three-dimensional conformal radiation therapy (3DCRT) is a mode of high precision radiotherapy which has the potential to improve the therapeutic ratio of radiation therapy for locally advanced non-small cell lung cancer. The preliminary clinical experience with 3DCRT has been promising and justifies further endeavour to refine its clinical application and ultimately test its role in randomized trials. There are several steps to be taken before 3DCRT evolves into an effective single modality for the treatment of lung cancer and before it is effectively integrated with chemotherapy. This article addresses core issues in the process of target volume definition for the application of 3DCRT technology to lung cancer. The International Commission on Radiation Units and Measurements Report no. 50 definitions of target volumes are used to identify the factors influencing target volumes in lung cancer. The rationale for applying 3DCRT to lung cancer is based on the frequency of failure to eradicate gross tumour with conventional approaches. It may therefore be appropriate to ignore subclinical or microscopic extensions when designing a clinical target volume, thereby restricting target volume size and allowing dose escalation. When the clinical target volume is expanded to a planning target volume, an optimized margin would result in homogeneous irradiation to the highest dose feasible within normal tissue constraints. To arrive at such optimized margins, multiple factors, including data acquisition, data transfer, patient movement, treatment reproducibility, and internal organ and target volume motion, must be considered. These factors may vary significantly depending on technology and techniques, and published quantitative analyses are no substitute for meticulous attention to detail and audit of performance.
Similar articles
-
Lymphatic drainage, CTV and molecular imaging in non-small cell lung cancer.Rays. 2003 Jul-Sep;28(3):299-302. Rays. 2003. PMID: 15018317 Review.
-
The impact of three-dimensional radiation on the treatment of non-small cell lung cancer.Radiother Oncol. 2000 Aug;56(2):157-67. doi: 10.1016/s0167-8140(00)00207-3. Radiother Oncol. 2000. PMID: 10927134 Review.
-
Defining target volumes for non-small cell lung carcinoma.Semin Radiat Oncol. 2004 Oct;14(4):308-14. doi: 10.1016/j.semradonc.2004.07.004. Semin Radiat Oncol. 2004. PMID: 15558505 Review.
-
[Lung cancer and elective nodal irradiation: A solved issue?].Cancer Radiother. 2019 Oct;23(6-7):701-707. doi: 10.1016/j.canrad.2019.06.008. Epub 2019 Sep 6. Cancer Radiother. 2019. PMID: 31501024 French.
-
Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.Strahlenther Onkol. 2002 Nov;178(11):651-8. doi: 10.1007/s00066-002-0939-2. Strahlenther Onkol. 2002. PMID: 12426677
Cited by
-
Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):453-62. doi: 10.1007/s00259-006-0252-x. Epub 2006 Oct 21. Eur J Nucl Med Mol Imaging. 2007. PMID: 17058078
-
Conformal radiotherapy for lung cancer: interobservers' variability in the definition of gross tumor volume between radiologists and radiotherapists.Radiat Oncol. 2009 Aug 5;4:28. doi: 10.1186/1748-717X-4-28. Radiat Oncol. 2009. PMID: 19653915 Free PMC article.
-
Dynamic MR based analysis of tumor movement in upper and mid lobe localized lung cancer.Pathol Oncol Res. 2009 Jun;15(2):269-77. doi: 10.1007/s12253-008-9101-5. Epub 2008 Sep 24. Pathol Oncol Res. 2009. PMID: 18814054
-
Magnetic resonance imaging in lung: a review of its potential for radiotherapy.Br J Radiol. 2016;89(1060):20150431. doi: 10.1259/bjr.20150431. Epub 2016 Feb 3. Br J Radiol. 2016. PMID: 26838950 Free PMC article. Review.
-
Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.BMC Cancer. 2007 Jun 28;7:112. doi: 10.1186/1471-2407-7-112. BMC Cancer. 2007. PMID: 17598906 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical